India to Turkey: Empagliflozin Export Trade Route
India has recorded 11 verified shipments of Empagliflozin exported to Turkey, representing a combined trade value of $220.7K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $20.1K USD. The leading Indian exporter is SCOTT EDIL PHARMACIA LIMITED , which accounts for 37% of total export value with 2 shipments worth $82.1K USD. On the buying side, DROV COMPANY is the largest importer in Turkey with $82.1K USD in purchases. The top 3 suppliers — SCOTT EDIL PHARMACIA LIMITED , HEXAMED LIFE SCIENCES LLP , HEXAMED LIFE SCIENCES LLP — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Turkey Empagliflozin corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $220.7K USD. The route is dominated by SCOTT EDIL PHARMACIA LIMITED , which alone accounts for roughly 37% of all export value, reflecting the consolidated nature of India's empagliflozin manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $20.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with empagliflozin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 25.9%, placing it at rank #5 among India's top empagliflozin export destinations globally.
On the import side, key buyers of Indian empagliflozin in Turkey include DROV COMPANY , TO THE ORDER OF , TO THE ORDER OF and 1 others. DROV COMPANY is the single largest importer with 2 shipments valued at $82.1K USD.
Route Characteristics
- Average transit32 days
- Peak seasonQ4
- Primary modeSea freight
- Top portCHAWAPAYAL ICD
Market Position
- Global rank#5
- Annual growth+25.9%
- Demand growth+21.8%
- Regulatory ease75/100
Top 10 Indian Empagliflozin Exporters to Turkey
Showing top 10 of 4 Indian suppliers exporting Empagliflozin to Turkey, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SCOTT EDIL PHARMACIA LIMITED Avg $41.1K per shipment | 2 | $82.1K | 37.2% |
| 2 | HEXAMED LIFE SCIENCES LLP Avg $34.0K per shipment | 2 | $68.1K | 30.8% |
| 3 | HEXAMED LIFE SCIENCES LLP Avg $53.7K per shipment | 1 | $53.7K | 24.3% |
| 4 | KWALITY PHARMACEUTICALS LIMITED Avg $2.8K per shipment | 6 | $16.8K | 7.6% |
This table shows the top 10 of 4 Indian companies exporting empagliflozin to Turkey, ranked by total trade value. The listed exporters are: SCOTT EDIL PHARMACIA LIMITED , HEXAMED LIFE SCIENCES LLP , HEXAMED LIFE SCIENCES LLP, KWALITY PHARMACEUTICALS LIMITED. SCOTT EDIL PHARMACIA LIMITED is the dominant supplier with 2 shipments worth $82.1K USD, giving it a 37% market share. The top 3 suppliers together account for 92% of the total trade value on this route.
Top 10 Empagliflozin Importers in Turkey
Showing top 10 of 4 known buyers in Turkey receiving Empagliflozin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian empagliflozin in Turkey include DROV COMPANY , TO THE ORDER OF , TO THE ORDER OF, K. S. ATLAS DIS TIC. LTD. STI.. The largest importer is DROV COMPANY , accounting for $82.1K USD across 2 shipments — representing 37% of all empagliflozin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DROV COMPANY | 2 | $82.1K | 37.2% |
| 2 | TO THE ORDER OF | 2 | $68.1K | 30.8% |
| 3 | TO THE ORDER OF | 1 | $53.7K | 24.3% |
| 4 | K. S. ATLAS DIS TIC. LTD. STI. | 6 | $16.8K | 7.6% |
Top 10 Empagliflozin Formulations Imported by Turkey
Showing top 10 of 5 product formulations shipped on the India to Turkey Empagliflozin route, ranked by trade value
Turkey imports a wide range of empagliflozin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HARMLESS MEDICINES FOR HUMAN CONSUMPTION-BATCH NO. T40466A/T40468A, MFG.DT: MAY-2024 EXP.DT: APRIL-2027, Empagliflozin 1 — accounts for $68.1K USD across 2 shipments. A total of 5 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HARMLESS MEDICINES FOR HUMAN CONSUMPTION-BATCH NO. T40466A/T40468A, MFG.DT: MAY-2024 EXP.DT: APRIL-2027, Empagliflozin 1 | 2 | $68.1K | 30.8% |
| 2 | EMPAGLIFLOZIN TAB 25MG (BATCH NO: XT3C05 | 1 | $62.0K | 28.1% |
| 3 | HARMLESS MEDICINES FOR HUMAN CONSUMPTION-EMPAGLIFLOZIN 12.5MG METFORMIN SR 1000MG( CELE EMPAMET 12.5/1000 )BATCH NO. : | 1 | $53.7K | 24.3% |
| 4 | EMPAGLIFLOZIN 12.5MG & METFORMIN HYDROCH | 1 | $20.1K | 9.1% |
| 5 | METFORMIN HYDROCHLORIDE AND EMPAGLIFLOZIN TABLETS 1000MG + 12.5MG (COMPOSITION:EACH FILM COATED TABLET CONTAINS: EMPAGLI | 6 | $16.8K | 7.6% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
CHAWAPAYAL ICD handles the highest volume with 6 shipments. Transit time averages 32 days by sea.
Market Dynamics
India's empagliflozin exports to Turkey are driven primarily by a handful of large-scale manufacturers. SCOTT EDIL PHARMACIA LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SCOTT EDIL PHARMACIA LIMITED , HEXAMED LIFE SCIENCES LLP , HEXAMED LIFE SCIENCES LLP — together account for 92% of total trade value on this route. The average shipment value of $20.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as empagliflozin tab 25mg (batch no: xt3c05 and harmless medicines for human consumption-empagliflozin 12.5mg metformin sr 1000mg( cele empamet 12.5/1000 )batch no. :, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DROV COMPANY is the largest importer with 2 shipments worth $82.1K USD — representing 37% of all empagliflozin imports from India on this route.
Route Statistics
- Trade Volume
- $220.7K
- Avg. Shipment
- $20.1K
- Suppliers
- 4
- Buyers
- 4
- Transit (Sea)
- ~32 days
- Annual Growth
- +25.9%
Related Analysis
Reverse Direction
Turkey → India — Empagliflozin (Import)Other Empagliflozin Routes
Unlock the Full India to Turkey Empagliflozin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 11 shipments on this route.
Frequently Asked Questions — India to Turkey Empagliflozin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Empagliflozin to Turkey?
The leading Indian exporters of Empagliflozin to Turkey are SCOTT EDIL PHARMACIA LIMITED , HEXAMED LIFE SCIENCES LLP , HEXAMED LIFE SCIENCES LLP. SCOTT EDIL PHARMACIA LIMITED holds the largest market share at approximately 37% of total trade value on this route.
Q What is the total value of Empagliflozin exports from India to Turkey?
India exports Empagliflozin to Turkey worth approximately $220.7K USD across 11 recorded shipments. The average value per shipment is $20.1K USD.
Q Which ports does India use to ship Empagliflozin to Turkey?
The most active port of origin is CHAWAPAYAL ICD with 6 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to Turkey for Empagliflozin?
The average transit time for Empagliflozin shipments from India to Turkey is approximately 32 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Turkey Empagliflozin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.9% with demand growth tracking at 21.8%. The route is ranked #5 among India's top Empagliflozin export destinations globally.
Q How many suppliers are active on the India to Turkey Empagliflozin route?
There are currently 4 active Indian suppliers exporting Empagliflozin to Turkey. The market is moderately concentrated with SCOTT EDIL PHARMACIA LIMITED accounting for 37% of total shipment value.
Q Who are the main importers of Empagliflozin from India in Turkey?
The leading importers of Indian Empagliflozin in Turkey include DROV COMPANY , TO THE ORDER OF , TO THE ORDER OF, K. S. ATLAS DIS TIC. LTD. STI.. DROV COMPANY is the largest buyer with 2 shipments worth $82.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Turkey export trade corridor identified from Indian Customs (DGFT) records for Empagliflozin.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 4 importers in Turkey matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 11 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists